Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2011, Article ID 908468, 13 pages
http://dx.doi.org/10.4061/2011/908468
Review Article

Recent Advances in Underlying Pathologies Provide Insight into Interleukin-8 Expression-Mediated Inflammation and Angiogenesis

1Department of Orthopedic Surgery Spine Unit, First Affiliated Hospital of Dalian Medical University, 222 Zhongshan Road, Dalian, Liaoning 116011, China
2Department of Pathology and Pathophysiology, Dalian Medical University, 9 West Section Lvshun South Road, Lvshun District, Dalian, Liaoning 116044, China

Received 23 April 2011; Revised 15 August 2011; Accepted 6 September 2011

Academic Editor: B. L. Slomiany

Copyright © 2011 Basit Saleem Qazi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Matsushima and J. J. Oppenheim, “Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF,” Cytokine, vol. 1, no. 1, pp. 2–13, 1989. View at Google Scholar · View at Scopus
  2. I. Dobreva, G. Waeber, R. W. James, and C. Widmann, “Interleukin-8 secretion by fibroblasts induced by low density lipoproteins is p38 MAPK-dependent and leads to cell spreading and wound closure,” Journal of Biological Chemistry, vol. 281, no. 1, pp. 199–205, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. M. Schröder, “The neutrophil-activating peptide 1/interleukin 8, a novel neutrophil chemotactic cytokine,” Archivum Immunologiae et Therapia Experimentalis, vol. 40, pp. 23–31, 1992. View at Google Scholar
  4. J. E. Feugate, Q. Li, L. Wong, and M. Martins-Green, “The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure,” Journal of Cell Biology, vol. 156, no. 1, pp. 161–172, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. N. Mukaida, A. Hishinuma, C. O. C. Zachariae, J. J. Oppenheim, and K. Matsushima, “Regulation of human interleukin 8 gene expression and binding of several other members of the intercrine family to receptors for interleukin-8,” Advances in Experimental Medicine and Biology, vol. 305, pp. 31–38, 1991. View at Google Scholar · View at Scopus
  6. M. Lotz, R. Terkeltaub, and P. M. Villiger, “Cartilage and joint inflammation: regulation of IL-8 expression by human articular chondrocytes,” Journal of Immunology, vol. 148, no. 2, pp. 466–473, 1992. View at Google Scholar · View at Scopus
  7. M. Baggiolini and I. Clark-Lewis, “Interleukin-8, a chemotactic and inflammatory cytokine,” FEBS Letters, vol. 307, no. 1, pp. 97–101, 1992. View at Publisher · View at Google Scholar
  8. J. J. Oppenheim, K. Matsushima, C. G. Larsen, and A. O. Anderson, “Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor,” Immunology, vol. 68, no. 1, pp. 31–36, 1989. View at Google Scholar
  9. Y. Terui, M. Ikeda, H. Tomizuka et al., “Activated endothelial cells induce apoptosis in leukemic cells by endothelial interleukin-8,” Blood, vol. 92, no. 8, pp. 2672–2680, 1998. View at Google Scholar
  10. R. Brew, J. S. Erkson, D. C. West, B. F. Flanagan, and S. E. Christmas, “Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro,” Biochemical Society Transactions, vol. 25, no. 2, p. 264S, 1997. View at Google Scholar
  11. J. M. Farber, “A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 14, pp. 5238–5242, 1990. View at Publisher · View at Google Scholar
  12. H. Zhang, G. H. Thorgaard, and S. S. Ristow, “Molecular cloning and genomic structure of an interleukin-8 receptor-like gene from homozygous clones of rainbow trout (Oncorhynchus mykiss),” Fish and Shellfish Immunology, vol. 13, no. 3, pp. 251–258, 2002. View at Publisher · View at Google Scholar
  13. M. Z. Norzila, K. Fakes, R. L. Henry, J. Simpson, and P. G. Gibson, “Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 3, part 1, pp. 769–774, 2000. View at Google Scholar
  14. M. L. Barnett, K. A. Lamb, K. M. Costello, and M. C. Pike, “Characterization of interleukin-8 receptors in human neutrophil membranes: regulation by guanine nucleotides,” Biochimica et Biophysica Acta, vol. 1177, no. 3, pp. 275–282, 1993. View at Publisher · View at Google Scholar
  15. C. Schumacher, I. Clark-Lewis, M. Baggiolini, and B. Moser, “High- and low-affinity binding of GROα and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 21, pp. 10542–10546, 1992. View at Publisher · View at Google Scholar
  16. D. H. Hechtman, M. I. Cybulsky, H. J. Fuchs, J. B. Baker, and M. A. Gimbrone, “Intravascular IL-8: inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation,” Journal of Immunology, vol. 147, no. 3, pp. 883–892, 1991. View at Google Scholar
  17. M. Krieger, T. Brunner, S. C. Bischoff et al., “Activation of human basophils through the IL-8 receptor,” Journal of Immunology, vol. 149, no. 8, pp. 2662–2667, 1992. View at Google Scholar
  18. F. Q. Cunha, B. B. Lorenzetti, S. Poole, and S. H. Ferreira, “Interleukin-8 as a mediator of sympathetic pain,” British Journal of Pharmacology, vol. 104, no. 3, pp. 765–767, 1991. View at Google Scholar
  19. K. J. van Zee, E. Fischer, A. S. Hawes et al., “Effects of intravenous IL-8 administration in nonhuman primates,” Journal of Immunology, vol. 148, no. 6, pp. 1746–1752, 1992. View at Google Scholar
  20. S. Nourshargh, J. A. Perkins, H. J. Showell, K. Matsushima, T. J. Williams, and P. D. Collins, “A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8,” Journal of Immunology, vol. 148, no. 1, pp. 106–111, 1992. View at Google Scholar
  21. A. E. Koch, P. J. Polverini, S. L. Kunkel et al., “Interleukin-8 as a macrophage-derived mediator of angiogenesis,” Science, vol. 258, no. 5089, pp. 1798–1801, 1992. View at Google Scholar
  22. W. S. Simonet, T. M. Hughes, H. Q. Nguyen, L. D. Trebasky, D. M. Danilenko, and E. S. Medlock, “Long-term impaired neutrophil migration in mice overexpressing human interleukin-8,” Journal of Clinical Investigation, vol. 94, no. 3, pp. 1310–1319, 1994. View at Google Scholar
  23. H. Nakamura, K. Yoshimura, N. G. McElvaney, and R. G. Crystal, “Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line,” Journal of Clinical Investigation, vol. 89, no. 5, pp. 1478–1484, 1992. View at Google Scholar
  24. S. C. Donnelly, R. M. Strieter, S. L. Kunkel et al., “Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups,” Lancet, vol. 341, no. 8846, pp. 643–647, 1993. View at Publisher · View at Google Scholar
  25. M. Marini, E. Vittori, J. Hollemborg, and S. Mattoli, “Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma,” Journal of Allergy and Clinical Immunology, vol. 89, no. 5, pp. 1001–1009, 1992. View at Publisher · View at Google Scholar
  26. T. J. Standiford, S. L. Kunkel, M. A. Basha et al., “Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung,” Journal of Clinical Investigation, vol. 86, no. 6, pp. 1945–1953, 1990. View at Google Scholar
  27. D. Armstrong, J. B. Jepson, C. A. Keele, and J. W. Stewart, “Pain-producing substance in human inflammatory exudates and plasma,” The Journal of physiology, vol. 135, no. 2, pp. 350–370, 1957. View at Google Scholar
  28. C. A. Dinarello, “Interleukin-1 and its biologically related cytokines,” Advances in Immunology, vol. 44, pp. 153–205, 1989. View at Google Scholar
  29. J. D. Levine and D. B. Reichling, “Peripheral mechanism of inflammatory pain,” in Textbook of Pain, pp. 1–59, Churchill livingstone, 4th edition, 1999. View at Google Scholar
  30. D. E. Hu, Y. Hori, and T. P. D. Fan, “Interleukin-8 stimulates angiogenesis in rats,” Inflammation, vol. 17, no. 2, pp. 135–143, 1993. View at Google Scholar
  31. Y. Kitadai, K. Haruma, K. Sumii et al., “Expression of interleukin-8 correlates with vascularity in human gastric carcinomas,” American Journal of Pathology, vol. 152, no. 1, pp. 93–100, 1998. View at Google Scholar
  32. M. W. Lingen, P. J. Polverini, and N. P. Bouck, “Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic,” American Journal of Pathology, vol. 149, no. 1, pp. 247–258, 1996. View at Google Scholar
  33. D. Schadendorf, A. Moller, B. Algermissen, M. Worm, M. Sticherling, and B. M. Czarnetzki, “IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor,” Journal of Immunology, vol. 151, no. 5, pp. 2667–2675, 1993. View at Google Scholar
  34. G. F. Greene, Y. Kitadai, C. A. Pettaway, A. C. Von Eschenbach, C. D. Bucana, and I. J. Fidler, “Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique,” American Journal of Pathology, vol. 150, no. 5, pp. 1571–1582, 1997. View at Google Scholar
  35. J. J. Lee, G. F. Leedale, and P. Bradbury, An Illustrated Guide to the Protozoa, Society of Protozoologists, Lawrence, Kan, USA, 2nd edition, 2000.
  36. L. Xu and I. J. Fidler, “Interleukin 8: an autocrine growth factor for human ovarian cancer,” Oncology Research, vol. 12, no. 2, pp. 97–106, 2000. View at Google Scholar
  37. F. Basolo, P. G. Conaldi, L. Fiore, S. Calvo, and A. Toniolo, “Normal breast epithelial cells produce interleukin 6 and 8 together with tumor-necrosis factor: defective IL6 expression in mammary carcinoma,” International Journal of Cancer, vol. 55, no. 6, pp. 926–930, 1993. View at Publisher · View at Google Scholar
  38. J. E. De Larco, B. R.K. Wuertz, K. A. Rosner et al., “A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells,” American Journal of Pathology, vol. 158, no. 2, pp. 639–646, 2001. View at Google Scholar
  39. A. R. Green, V. L. Green, M. C. White, and V. Speirs, “Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours,” International Journal of Cancer, vol. 72, no. 6, pp. 937–941, 1997. View at Publisher · View at Google Scholar
  40. S. J. Youngs, S. A. Ali, D. D. Taub, and R. C. Rees, “Chemokines induce migrational responses in human breast carcinoma cell lines,” International Journal of Cancer, vol. 71, no. 2, pp. 257–266, 1997. View at Publisher · View at Google Scholar
  41. P. S. Gilmour, I. Rahman, K. Donaldson, and W. MacNee, “Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles,” American Journal of Physiology, vol. 284, no. 3, pp. L533–L540, 2003. View at Google Scholar
  42. G. J. Rosenthal, D. R. Germolec, M. E. Blazka et al., “Asbestos stimulates IL-8 production from human lung epithelial cells,” Journal of Immunology, vol. 153, no. 7, pp. 3237–3244, 1994. View at Google Scholar
  43. C. K. Sen, “Cellular thiols and redox-regulated signal transduction,” Current Topics in Cellular Regulation, vol. 36, pp. 1–30, 2000. View at Google Scholar
  44. G. Broughton II, J. E. Janis, and C. E. Attinger, “The basic science of wound healing,” Plastic and Reconstructive Surgery, vol. 117, supplement 7, pp. 12S–34S, 2006. View at Publisher · View at Google Scholar · View at PubMed
  45. N. Vij, A. Sharma, M. Thakkar, S. Sinha, and R. R. Mohan, “PDGF-driven proliferation, migration, and IL8 chemokine secretion in human corneal fibroblasts involve JAK2-STAT3 signaling pathway,” Molecular Vision, vol. 14, pp. 1020–1027, 2008. View at Google Scholar
  46. E. Hoffmann, O. Dittrich-Breiholz, H. Holtmann, and M. Kracht, “Multiple control of interleukin-8 gene expression,” Journal of Leukocyte Biology, vol. 72, no. 5, pp. 847–855, 2002. View at Google Scholar
  47. M. Kracht and J. Saklatvala, “Transcriptional and post-transcriptional control of gene expression in inflammation,” Cytokine, vol. 20, no. 3, pp. 91–106, 2002. View at Publisher · View at Google Scholar
  48. J. Chodosh, R. A. Astley, M. G. Butler, and R. C. Kennedy, “Adenovirus keratitis: a role for interleukin-8,” Investigative Ophthalmology and Visual Science, vol. 41, no. 3, pp. 783–789, 2000. View at Google Scholar
  49. J. V. Jester, J. Huang, W. M. Petroll, and H. D. Cavanagh, “TGFβ induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFβ, PDGF and integrin signaling,” Experimental Eye Research, vol. 75, no. 6, pp. 645–657, 2002. View at Publisher · View at Google Scholar
  50. N. J. Stevenson, S. Haan, A. E. McClurg et al., “The chemoattractants, IL-8 and formyl-methionyl-leucyl-phenylalanine, regulate granulocyte colony-stimulating factor signaling by inducing suppressor of cytokine signaling-1 expression,” Journal of Immunology, vol. 173, no. 5, pp. 3243–3249, 2004. View at Google Scholar
  51. J. E. Oakes, C. A. Monteiro, C. L. Cubitt, and R. N. Lausch, “Induction of interleukin-8 gene expression is associated with herpes simplex virus infection of human corneal keratocytes but not human corneal epithelial cells,” Journal of Virology, vol. 67, no. 8, pp. 4777–4784, 1993. View at Google Scholar
  52. R. Gillitzer, R. Berger, V. Mielke, C. Muller, K. Wolff, and G. Stingl, “Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ,” Journal of Investigative Dermatology, vol. 97, no. 1, pp. 73–79, 1991. View at Google Scholar
  53. A. E. Koch, S. L. Kunkel, J. C. Burrows et al., “Synovial tissue macrophage as a source of the chemotactic cytokine IL-8,” Journal of Immunology, vol. 147, no. 7, pp. 2187–2195, 1991. View at Google Scholar
  54. K. J. van Zee, L. E. DeForge, E. Fischer et al., “IL-8 in septic shock, endotoxemia, and after IL-1 administration,” Journal of Immunology, vol. 146, no. 10, pp. 3478–3482, 1991. View at Google Scholar
  55. H. Zwierzina, I. Holzinger, S. Gaggl et al., “Recombinant human interleukin-8 restores function in neutrophils from patients with myelodysplastic syndromes without stimulating myeloid progenitor cells,” Scandinavian Journal of Immunology, vol. 37, no. 3, pp. 322–328, 1993. View at Google Scholar
  56. S. Z. Ding, Y. Minohara, J. F. Xue et al., “Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells,” Infection and Immunity, vol. 75, no. 8, pp. 4030–4039, 2007. View at Publisher · View at Google Scholar · View at PubMed
  57. S. E. Crowe, “Helicobacter infection, chronic inflammation, and the development of malignancy,” Current Opinion in Gastroenterology, vol. 21, no. 1, pp. 32–38, 2005. View at Google Scholar
  58. P. B. Ernst, D. A. Peura, and S. E. Crowe, “The translation of Helicobacter pylori basic research to patient care,” Gastroenterology, vol. 130, no. 1, pp. 188–206, 2006. View at Publisher · View at Google Scholar · View at PubMed
  59. S. E. Crowe, L. Alvarez, M. Dytoc et al., “Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro,” Gastroenterology, vol. 108, no. 1, pp. 65–74, 1995. View at Publisher · View at Google Scholar
  60. J. E. Crabtree, J. I. Wyatt, L. K. Trejdosiewicz et al., “Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa,” Journal of Clinical Pathology, vol. 47, no. 1, pp. 61–66, 1994. View at Google Scholar
  61. J. E. Crabtree, T. M. Shallcross, R. V. Heatley, and J. I. Wyatt, “Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pyloris associated gastritis,” Gut, vol. 32, no. 12, pp. 1473–1477, 1991. View at Google Scholar
  62. S. F. Moss and M. J. Blaser, “Mechanisms of disease: inflammation and the origins of cancer,” Nature Clinical Practice Oncology, vol. 2, no. 2, pp. 90–97, 2005. View at Publisher · View at Google Scholar · View at PubMed
  63. H. M. Shen and S. Pervaiz, “TNF receptor superfamily-induced cell death: redox-dependent execution,” FASEB Journal, vol. 20, no. 10, pp. 1589–1598, 2006. View at Publisher · View at Google Scholar · View at PubMed
  64. G. Chen and D. V. Goeddel, “TNF-R1 signaling: a beautiful pathway,” Science, vol. 296, no. 5573, pp. 1634–1635, 2002. View at Publisher · View at Google Scholar · View at PubMed
  65. T. Shimada, N. Watanabe, H. Hiraishi, and A. Terano, “Redox regulation of interleukin-8 expression in MKN28 cells,” Digestive Diseases and Sciences, vol. 44, no. 2, pp. 266–273, 1999. View at Google Scholar
  66. F. Yan, S. K. John, G. Wilson, D. S. Jones, M. K. Washington, and D. B. Polk, “Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation,” Journal of Clinical Investigation, vol. 114, no. 9, pp. 1272–1280, 2004. View at Publisher · View at Google Scholar
  67. S. Chollet-Martin, B. Jourdain, C. Gibert, C. Elbim, J. Chastre, and M. A. Gougerot-Pocidalo, “Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3, part 1, pp. 594–601, 1996. View at Google Scholar
  68. K. P. Steinberg, J. A. Milberg, T. R. Martin, R. J. Maunder, B. A. Cockrill, and L. D. Hudson, “Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 1, pp. 113–122, 1994. View at Google Scholar
  69. R. B. Goodman, R. M. Strieter, D. P. Martin et al., “Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 3, part 1, pp. 602–611, 1996. View at Google Scholar
  70. J. Pugin, B. Ricou, K. P. Steinberg, P. M. Suter, and T. R. Martin, “Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 6, part 1, pp. 1850–1856, 1996. View at Google Scholar
  71. R. P. Baughman, K. L. Gunther, M. C. Rashkin, D. A. Keeton, and E. N. Pattishall, “Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 1, pp. 76–81, 1996. View at Google Scholar
  72. N. Sekido, N. Mukaida, A. Harada, I. Nakanishi, Y. Watanabe, and K. Matsushima, “Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8,” Nature, vol. 365, no. 6447, pp. 654–657, 1993. View at Publisher · View at Google Scholar · View at PubMed
  73. A. P. Metinko, S. L. Kunkel, T. J. Standiford, and R. M. Strieter, “Anoxia-hyperoxia induces monocyte-derived interleukin-8,” Journal of Clinical Investigation, vol. 90, no. 3, pp. 791–798, 1992. View at Google Scholar
  74. L. E. DeForge, A. M. Preston, E. Takeuchi, J. Kenney, L. A. Boxer, and D. G. Remick, “Regulation of interleukin 8 gene expression by oxidant stress,” Journal of Biological Chemistry, vol. 268, no. 34, pp. 25568–25576, 1993. View at Google Scholar
  75. V. Lakshminarayanan, D. W. A. Beno, R. H. Costa, and K. A. Roebuck, “Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factor-α in endothelial and epithelial cells,” Journal of Biological Chemistry, vol. 272, no. 52, pp. 32910–32918, 1997. View at Publisher · View at Google Scholar
  76. R. J. Anto, A. Mukhopadhyay, S. Shishodia, C. G. Gairola, and B. B. Aggarwal, “Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα: correlation with induction of cyclooxygenase-2,” Carcinogenesis, vol. 23, no. 9, pp. 1511–1518, 2002. View at Google Scholar
  77. A. Richter, R. A. O'Donnell, R. M. Powell et al., “Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke,” American Journal of Respiratory Cell and Molecular Biology, vol. 27, no. 1, pp. 85–90, 2002. View at Google Scholar
  78. U. Suter, A. A. Welcher, T. Ozcelik et al., “Trembler mouse carries a point mutation in a myelin gene,” Nature, vol. 356, no. 6366, pp. 241–244, 1992. View at Publisher · View at Google Scholar · View at PubMed
  79. V. C. Broaddus, A. M. Boylan, J. M. Hoeffel et al., “Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy,” Journal of Immunology, vol. 152, no. 6, pp. 2960–2967, 1994. View at Google Scholar
  80. K. Modelska, J. F. Pittet, H. G. Folkesson, V. Courtney Broaddus, and M. A. Matthay, “Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 5, pp. 1450–1456, 1999. View at Google Scholar
  81. T. M. Roebuck, S. N. Mattson, and E. P. Riley, “Behavioral and psychosocial profiles of alcohol-exposed children,” Alcoholism: Clinical and Experimental Research, vol. 23, no. 6, pp. 1070–1076, 1999. View at Google Scholar
  82. H. Chandru and V. Boggaram, “The role of sphingosine 1-phosphate in the TNF-α induction of IL-8 gene expression in lung epithelial cells,” Gene, vol. 391, no. 1-2, pp. 150–160, 2007. View at Publisher · View at Google Scholar · View at PubMed
  83. S. M. Rowe, S. Miller, and E. J. Sorscher, “Cystic fibrosis,” New England Journal of Medicine, vol. 352, no. 19, pp. 1992–2001, 2005. View at Publisher · View at Google Scholar · View at PubMed
  84. M. M. Zaman, A. Gelrud, O. Junaidi et al., “Interleukin 8 secretion from monocytes of subjects heterozygous for the ΔF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 5, pp. 819–824, 2004. View at Publisher · View at Google Scholar · View at PubMed
  85. S. Caristi, G. Piraino, M. Cucinotta, A. Valenti, S. Loddo, and D. Teti, “Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes,” Journal of Biological Chemistry, vol. 280, no. 15, pp. 14433–14442, 2005. View at Publisher · View at Google Scholar · View at PubMed
  86. D. S. Armstrong, K. Grimwood, R. Carzino, J. B. Carlin, A. Olinsky, and P. D. Phelan, “Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis,” British Medical Journal, vol. 310, no. 6994, pp. 1571–1572, 1995. View at Google Scholar
  87. M. W. Konstan, K. A. Hilliard, T. M. Norvell, and M. Berger, “Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 150, no. 2, pp. 448–454, 1994. View at Google Scholar
  88. E. DiMango, H. J. Zar, R. Bryan, and A. Prince, “Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8,” Journal of Clinical Investigation, vol. 96, no. 5, pp. 2204–2210, 1995. View at Google Scholar
  89. K. Barnett, D. B. Jacoby, J. A. Nadel, and S. C. Lazarus, “The effects of epithelial cell supernatant on contractions of isolated canine tracheal smooth muscle,” American Review of Respiratory Disease, vol. 138, no. 4, pp. 780–783, 1988. View at Google Scholar
  90. G. D. Leikauf, I. F. Ueki, J. H. Widdicombe, and J. A. Nadel, “Alteration of chloride secretion across canine tracheal epithelium by lipoxygenase products of arachidonic acid,” American Journal of Physiology, vol. 250, no. 1, part 2, pp. F47–F53, 1986. View at Google Scholar
  91. B. Poligone and A. S. Baldwin, “Positive and negative regulation of NF-κB by COX-2. Roles of different prostaglandins,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 38658–38664, 2001. View at Publisher · View at Google Scholar · View at PubMed
  92. A. Agro, C. Langdon, F. Smith, and C. D. Richards, “Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro,” Journal of Rheumatology, vol. 23, no. 5, pp. 862–868, 1996. View at Google Scholar
  93. N. Sigurs, P. M. Gustafsson, R. Bjarnason et al., “Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 2, pp. 137–141, 2005. View at Publisher · View at Google Scholar · View at PubMed
  94. Q. Xiu, M. Fujimura, M. Nomura et al., “Bronchial hyperresponsiveness and airway neutrophil accumulation induced by interleukin-8 and the effect of the thromboxane A2 antagonist S-1452 in guinea-pigs,” Clinical and Experimental Allergy, vol. 25, no. 1, pp. 51–59, 1995. View at Publisher · View at Google Scholar
  95. A. Heinzmann, I. Ahlert, T. Kurz, R. Berner, and K. A. Deichmann, “Association study suggests opposite effects of polymorphisms within IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis,” Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. 671–676, 2004. View at Publisher · View at Google Scholar · View at PubMed
  96. K. Mitsuyama, A. Toyonaga, E. Sasaki et al., “IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease,” Clinical and Experimental Immunology, vol. 96, no. 3, pp. 432–436, 1994. View at Google Scholar
  97. C. P. Braegger, S. Nicholls, S. H. Murch, S. Stephens, and T. T. MacDonald, “Tumour necrosis factor alpha in stool as a marker of intestinal inflammation,” Lancet, vol. 339, no. 8785, pp. 89–91, 1992. View at Publisher · View at Google Scholar
  98. L. Eckmann, H. C. Jung, C. Schurer-Maly, A. Panja, E. Morzycka-Wroblewska, and M. F. Kagnoff, “Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8,” Gastroenterology, vol. 105, no. 6, pp. 1689–1697, 1993. View at Google Scholar
  99. Y. R. Mahida, M. Ceska, F. Effenberger, L. Kurlak, I. Lindley, and C. J. Hawkey, “Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis,” Clinical Science, vol. 82, no. 3, pp. 273–275, 1992. View at Google Scholar
  100. R. S. Izzo, K. Witkon, A. I. Chen, C. Hadjiyane, M. I. Weinstein, and C. Pellecchia, “Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease,” Scandinavian Journal of Gastroenterology, vol. 28, no. 4, pp. 296–300, 1993. View at Google Scholar
  101. D. P. Braun, H. Gebel, R. House, N. Rana, and W. P. Dmowski, “Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis,” Fertility and Sterility, vol. 65, no. 6, pp. 1125–1129, 1996. View at Google Scholar
  102. H. O. D. Critchley, R. W. Kelly, and J. Kooy, “Perivascular location of a chemokine interleukin-8 in human endometrium: a preliminary report,” Human Reproduction, vol. 9, no. 8, pp. 1406–1409, 1994. View at Google Scholar
  103. M. B. Furie and G. J. Randolph, “Chemokines and tissue injury,” American Journal of Pathology, vol. 146, no. 6, pp. 1287–1301, 1995. View at Google Scholar
  104. O. Khorram, R. N. Taylor, I. P. Ryan, T. J. Schall, and D. V. Landers, “Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis,” American Journal of Obstetrics and Gynecology, vol. 169, no. 6, pp. 1545–1549, 1993. View at Google Scholar
  105. M. Van Deuren, A. S. M. Dofferhoff, and J. W. M. Van der Meer, “Cytokines and the response to infection,” Journal of Pathology, vol. 168, no. 4, pp. 349–356, 1992. View at Publisher · View at Google Scholar · View at PubMed
  106. I. P. Ryan, J. F. Tseng, E. D. Schriock, O. Khorram, D. V. Landers, and R. N. Taylor, “Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis,” Fertility and Sterility, vol. 63, no. 4, pp. 929–932, 1995. View at Google Scholar
  107. N. Rana, D. P. Braun, R. House, H. Gebel, C. Rotman, and W. P. Dmowski, “Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis,” Fertility and Sterility, vol. 65, no. 5, pp. 925–930, 1996. View at Google Scholar
  108. S. Saito, T. Kasahara, S. Sakakura, H. Umekage, N. Harada, and M. Ichijo, “Detection and localization of interleukin-8 mRNA and protein in human placenta and decidual tissues,” Journal of Reproductive Immunology, vol. 27, no. 3, pp. 161–172, 1994. View at Publisher · View at Google Scholar
  109. A. Arici, P. C. MacDonald, and M. L. Casey, “Progestin regulation of interleukin-8 mRNA levels and protein synthesis in human endometrial stromal cells,” Journal of Steroid Biochemistry and Molecular Biology, vol. 58, no. 1, pp. 71–76, 1996. View at Publisher · View at Google Scholar
  110. J. G. Burke, R. W. G. Watson, D. McCormack, F. E. Dowling, M. G. Walsh, and J. M. Fitzpatrick, “Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators,” Journal of Bone and Joint Surgery, Series B, vol. 84, no. 2, pp. 196–201, 2002. View at Google Scholar
  111. J. D. Kang, M. Stefanovic-Racic, L. A. McIntyre, H. I. Georgescu, and C. H. Evans, “Toward a biochemical understanding of human intervertebral disc degeneration and herniation: contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases,” Spine, vol. 22, no. 10, pp. 1065–1073, 1997. View at Publisher · View at Google Scholar
  112. J. M. Cunha, F. Q. Cunha, S. Poole, and S. H. Ferreira, “Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist,” British Journal of Pharmacology, vol. 130, no. 6, pp. 1418–1424, 2000. View at Google Scholar
  113. A. Li, M. L. Varney, J. Valasek, M. Godfrey, B. J. Dave, and R. K. Singh, “Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis,” Angiogenesis, vol. 8, no. 1, pp. 63–71, 2005. View at Publisher · View at Google Scholar · View at PubMed
  114. B. M. Mian, C. P. N. Dinney, C. E. Bermejo et al., “Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-κB,” Clinical Cancer Research, vol. 9, no. 8, pp. 3167–3175, 2003. View at Google Scholar
  115. J. Yoneda, H. Kuniyasu, M. A. Crispens, J. E. Price, C. D. Bucana, and I. J. Fidler, “Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice,” Journal of the National Cancer Institute, vol. 90, no. 6, pp. 447–454, 1998. View at Google Scholar
  116. A. E. Lokshin, M. Winans, D. Landsittel et al., “Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer,” Gynecologic Oncology, vol. 102, no. 2, pp. 244–251, 2006. View at Publisher · View at Google Scholar · View at PubMed
  117. T. Karashima, P. Sweeney, A. Kamat et al., “Nuclear factor-κB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8,” Clinical Cancer Research, vol. 9, no. 7, pp. 2786–2797, 2003. View at Google Scholar
  118. J. G. Trevino, M. J. Gray, S. T. Nawrocki et al., “Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells,” Angiogenesis, vol. 9, no. 2, pp. 101–110, 2006. View at Publisher · View at Google Scholar · View at PubMed
  119. W. M. Merritt, Y. G. Lin, W. A. Spannuth et al., “Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth,” Journal of the National Cancer Institute, vol. 100, no. 5, pp. 359–372, 2008. View at Publisher · View at Google Scholar · View at PubMed
  120. K. Xie, “Interleukin-8 and human cancer biology,” Cytokine and Growth Factor Reviews, vol. 12, no. 4, pp. 375–391, 2001. View at Publisher · View at Google Scholar
  121. S. K. Kassim, E. M. El-Salahy, S. T. Fayed et al., “Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients,” Clinical Biochemistry, vol. 37, no. 5, pp. 363–369, 2004. View at Publisher · View at Google Scholar · View at PubMed
  122. A. Fasciani, G. D'Ambrogio, G. Bocci, S. Luisi, P. G. Artini, and A. R. Genazzani, “Vascular endothelial growth factor and interleukin-8 in ovarian cystic pathology,” Fertility and Sterility, vol. 75, no. 6, pp. 1218–1221, 2001. View at Publisher · View at Google Scholar
  123. C. A. Herrera, L. Xu, C. D. Bucana et al., “Expression of metastasis-related genes in human epithelial ovarian tumors,” International Journal of Oncology, vol. 20, no. 1, pp. 5–13, 2002. View at Google Scholar
  124. S. Huang, L. Mills, B. Mian et al., “Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma,” American Journal of Pathology, vol. 161, no. 1, pp. 125–134, 2002. View at Google Scholar
  125. A. Li, S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh, “IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis,” Journal of Immunology, vol. 170, no. 6, pp. 3369–3376, 2003. View at Google Scholar
  126. M. Luca, S. Huang, J. E. Gershenwald, R. K. Singh, R. Reich, and M. Bar-Eli, “Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis,” American Journal of Pathology, vol. 151, no. 4, pp. 1105–1113, 1997. View at Google Scholar
  127. B. Farrow, Y. Sugiyama, A. Chen et al., “Inflammatory mechanisms contributing to pancreatic cancer development,” Annals of Surgery, vol. 239, no. 6, pp. 763–771, 2004. View at Publisher · View at Google Scholar
  128. Y. Matsuo, H. Sawai, H. Funahashi et al., “Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential,” Pancreas, vol. 28, no. 3, pp. 344–352, 2004. View at Publisher · View at Google Scholar
  129. B. Ebrahimi, S. L. Tucker, D. Li, J. L. Abbruzzese, and R. Kurzrock, “Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis,” Cancer, vol. 101, no. 12, pp. 2727–2736, 2004. View at Publisher · View at Google Scholar · View at PubMed
  130. X. Le, Q. Shi, B. Wang et al., “Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma,” Journal of Interferon and Cytokine Research, vol. 20, no. 11, pp. 935–946, 2000. View at Publisher · View at Google Scholar · View at PubMed
  131. Y. Kuwada, T. Sasaki, K. Morinaka, Y. Kitadai, N. Mukaida, and K. Chayama, “Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells,” International Journal of Oncology, vol. 22, no. 4, pp. 765–771, 2003. View at Google Scholar
  132. M. Miyamoto, Y. Shimizu, K. Okada, Y. Kashii, K. Higuchi, and A. Watanabe, “Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells,” Cancer Immunology Immunotherapy, vol. 47, no. 1, pp. 47–57, 1998. View at Publisher · View at Google Scholar
  133. Q. Shi, J. L. Abbruzzese, S. Huang, I. J. Fidler, Q. Xiong, and K. Xie, “Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic,” Clinical Cancer Research, vol. 5, no. 11, pp. 3711–3721, 1999. View at Google Scholar
  134. E. Feijoó, C. Alfaro, G. Mazzolini et al., “Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8,” International Journal of Cancer, vol. 116, no. 2, pp. 275–281, 2005. View at Publisher · View at Google Scholar · View at PubMed
  135. M. N. Wente, M. P. Keane, M. D. Burdick et al., “Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis,” Cancer Letters, vol. 241, no. 2, pp. 221–227, 2006. View at Publisher · View at Google Scholar · View at PubMed
  136. M. Li, Y. Zhang, L. W. Feurino et al., “Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer,” Cancer Science, vol. 99, no. 4, pp. 733–737, 2008. View at Publisher · View at Google Scholar · View at PubMed
  137. B. B. Moore, D. A. Arenberg, K. Stoy et al., “Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells,” American Journal of Pathology, vol. 154, no. 5, pp. 1503–1512, 1999. View at Google Scholar
  138. R. W. Veltri, M. C. Miller, G. Zhao et al., “Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer,” Urology, vol. 53, no. 1, pp. 139–147, 1999. View at Publisher · View at Google Scholar
  139. S. Lehrer, E. J. Diamond, B. Mamkine, N. N. Stone, and R. G. Stock, “Serum interleukin-8 is elevated in men with prostate cancer and bone metastases,” Technology in Cancer Research and Treatment, vol. 3, no. 5, p. 411, 2004. View at Google Scholar
  140. J. Reiland, L. T. Furcht, and J. B. McCarthy, “CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor,” Prostate, vol. 41, no. 2, pp. 78–88, 1999. View at Publisher · View at Google Scholar
  141. B. J. Patel, A. J. Pantuck, A. Zisman et al., “Cl1-GFP: an androgen independent metastatic tumor model for prostate cancer,” Journal of Urology, vol. 164, no. 4, pp. 1420–1425, 2000. View at Google Scholar
  142. J. Huang, J. L. Yao, L. Zhang et al., “Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer,” American Journal of Pathology, vol. 166, no. 6, pp. 1807–1815, 2005. View at Google Scholar
  143. A. Freund, C. Chauveau, J. P. Brouillet et al., “IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells,” Oncogene, vol. 22, no. 2, pp. 256–265, 2003. View at Publisher · View at Google Scholar · View at PubMed
  144. K. Ivarsson, E. Runesson, K. Sundfeldt et al., “The chemotactic cytokine interleukin-8—a cyst fluid marker for malignant epithelial ovarian cancer?” Gynecologic Oncology, vol. 71, no. 3, pp. 420–423, 1998. View at Publisher · View at Google Scholar · View at PubMed
  145. A. J. Merogi, A. J. Marrogi, R. Ramesh, W. R. Robinson, C. D. Fermin, and S. M. Freeman, “Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas,” Human Pathology, vol. 28, no. 3, pp. 321–331, 1997. View at Publisher · View at Google Scholar
  146. V. Speirs, A. R. Green, and M. C. White, “A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples,” International Journal of Cancer, vol. 66, no. 4, pp. 551–556, 1996. View at Publisher · View at Google Scholar
  147. M. W. Madsen and P. Briand, “Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines,” European Journal of Cancer, vol. 26, no. 7, pp. 793–797, 1990. View at Publisher · View at Google Scholar
  148. H. Sprenger, A. R. Lloyd, L. L. Lautens, T. I. Bonner, and D. J. Kelvin, “Structure, genomic organization, and expression of the human interleukin- 8 receptor B gene,” Journal of Biological Chemistry, vol. 269, no. 15, pp. 11065–11072, 1994. View at Google Scholar
  149. H. Sprenger, A. R. Lloyd, R. G. Meyer, J. A. Johnston, and D. J. Kelvin, “Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene,” Journal of Immunology, vol. 153, no. 6, pp. 2524–2532, 1994. View at Google Scholar
  150. L. J. Miller, S. H. Kurtzman, Y. Wang, K. H. Anderson, R. R. Lindquist, and D. L. Kreutzer, “Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue,” Anticancer Research, vol. 18, no. 1, pp. 77–81, 1998. View at Google Scholar
  151. A. Müller, B. Homey, H. Soto et al., “Involvement of chemokine receptors in breast cancer metastasis,” Nature, vol. 410, no. 6824, pp. 50–56, 2001. View at Publisher · View at Google Scholar · View at PubMed
  152. L.-F. Lee, R. P. Hellendall, Y. Wang et al., “IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration,” Journal of Immunology, vol. 164, no. 5, pp. 2769–2775, 2000. View at Google Scholar
  153. E. Nakashima, A. Oya, Y. Kubota et al., “A candidate for cancer gene therapy: MIP-1α gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice,” Pharmaceutical Research, vol. 13, no. 12, pp. 1896–1901, 1996. View at Publisher · View at Google Scholar
  154. K. Inoue, J. W. Slaton, B. Y. Eve et al., “Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer,” Clinical Cancer Research, vol. 6, no. 5, pp. 2104–2119, 2000. View at Google Scholar
  155. N. Platet and M. Garcia, “A new bioassay using transient transfection for invasion-related gene analysis,” Invasion and Metastasis, vol. 18, no. 4, pp. 198–208, 1998. View at Google Scholar
  156. M. Hsu, S. Y. Wu, S. S. Chang et al., “Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells,” Journal of Virology, vol. 82, no. 7, pp. 3679–3688, 2008. View at Publisher · View at Google Scholar · View at PubMed
  157. A. B. Rickinson and E. Kieff, “Epstein-Barr virus,” in Fields Virology, D. M. Knipe and P. M. Howley, Eds., pp. 2575–2627, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 4th edition, 2001. View at Google Scholar
  158. H. Chen, J. M. Lee, Y. Zong et al., “Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors,” Journal of Virology, vol. 75, no. 6, pp. 2929–2937, 2001. View at Publisher · View at Google Scholar · View at PubMed
  159. M. Buettner, B. Meyer, S. Schreck, and G. Niedobitek, “Expression of RANTES and MCP-1 in epithelial cells is regulated via LMP1 and CD40,” International Journal of Cancer, vol. 121, no. 12, pp. 2703–2710, 2007. View at Publisher · View at Google Scholar · View at PubMed
  160. P. Scapini, J. A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni, and M. A. Cassatella, “The neutrophil as a cellular source of chemokines,” Immunological Reviews, vol. 177, pp. 195–203, 2000. View at Google Scholar
  161. A. S. Haqqani, J. K. Sandhu, and H. C. Birnboim, “Expression of interleukin-8 promotes neutrophil infiltration and genetic instability in mutatect tumors,” Neoplasia, vol. 2, no. 6, pp. 561–568, 2000. View at Google Scholar
  162. A. Sparmann and D. Bar-Sagi, “Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis,” Cancer Cell, vol. 6, no. 5, pp. 447–458, 2004. View at Publisher · View at Google Scholar · View at PubMed
  163. Q. Sun, H. Matta, G. Lu, and P. M. Chaudhary, “Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-κB activation,” Oncogene, vol. 25, no. 19, pp. 2717–2726, 2006. View at Publisher · View at Google Scholar · View at PubMed
  164. A. E. Koch, S. L. Kunkel, L. A. Harlow et al., “Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis,” Journal of Clinical Investigation, vol. 90, no. 3, pp. 772–779, 1992. View at Google Scholar
  165. P. Peveri, A. Walz, B. Dewald, and M. Baggiolini, “A novel neutrophil-activating factor produced by human mononuclear phagocytes,” Journal of Experimental Medicine, vol. 167, no. 5, pp. 1547–1559, 1988. View at Google Scholar